Skip to content Skip to navigation

SIGF: Stanford Interdisciplinary Graduate Fellowship

About SIGF

The Stanford Interdisciplinary Graduate Fellowship (SIGF) is a competitive, university-wide program that awards three-year fellowships to outstanding doctoral students engaged in interdisciplinary research.

View SIGF details

The 2019 SIGF application opened Tuesday, January 8, 2019.

APPLY HERE

The application deadline is Monday, February 25, 2019 at 11:59PM.

Contact sigf@stanford.edu with any questions. Review info session slides for more information.

Recent News

a person in a white coat holds a stethoscope up to the heart of a child
Jan 28 2019 | Stanford Report
For children undergoing immunotherapy – a promising treatment for peanut allergies – uncomfortable side effects can induce anxiety, perhaps to the point of skipping doses or dropping treatment entirely. But guiding young patients to the mindset that uncomfortable side effects are a sign that...
Image of three brain cell types: oligodendrocytes (green), neurons (magenta) and astrocytes (blue)
Jan 28 2019 | Stanford Medicine
For proper brain function, it’s crucial that certain neurons be wrapped with myelin, a coating that enhances impulse transmission. Failure can spell outcomes ranging from cerebral palsy to multiple sclerosis. A better understanding of oligodendrocytes, the brain cells that make myelin, might help...
close up of two hands coming from a person white medical coat are gripping another person's hand
Jan 22 2019 | The New York Times
In the age of the internet, it’s easier than ever to pull together lots of information to find the best doctor. And if you’re like most patients, the metric you probably rely on most is the doctor’s credentials. Where did she go to school? How many patients has he treated with this condition? You...
close up of an assortment of unmarked capsule-shaped and round pills of different colors
Jan 5 2019 | ABC News
A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain cancer drug, one that might have ended up overlooked by pharmaceutical companies. The lead researcher on the team, Dr. Teresa Purzner has...